online pharmacy, prescription drugs online



Drugs online research references









  • Binding study of sulfonylureas and phenothiazines to bovine serum albumin using difference spectrophotometry.
  • G-proteins and hormonal inhibition of insulin secretion from HIT-T15 cells and isolated rat islets.
  • Parenteral administration of glipizide sodium salt, an inhibitor of adenosine triphosphate-sensitive potassium channels, prolongs short-term survival after severe controlled hemorrhage in rats.
  • Rx drugs
  • Effects of rosiglitazone maleate when added to a sulfonylurea regimen in patients with type 2 diabetes mellitus and mild to moderate renal impairment: a post hoc analysis.
  • Expression of the 64 kDa/glutamic acid decarboxylase rat islet cell autoantigen is influenced by the rate of insulin secretion.
  • Effect of glipizide on serum insulin and glucose concentrations in healthy cats.
  • Conversion from glipizide to glyburide: a prospective cost-impact survey.
  • Islet allografts in the cryptorchid testes of spontaneously diabetic BB/Wor dp rats: response to glucose, glipizide, and arginine.
  • Antidiabetic sulfonylureas relax isolated rabbit coronary arteries.
  • Changes in carbohydrate metabolism in association with glipizide treatment of type 2 diabetes.
  • Effects of a water-soluble extract of maitake mushroom on circulating glucose/insulin concentrations in KK mice.
  • Chiral recognition of pinacidil and its 3-pyridyl isomer by canine cardiac and smooth muscle: antagonism by sulfonylureas.
  • Crossover comparison of maximum dose glyburide and glipizide.
  • Improvement of glucose-primed intravenous glucose tolerance and correction of acute insulin decrement by glipizide in type II diabetes.
  • The nature of the pancreatic hormone secretion and of the metabolic indices during the acute and chronic administration of peroral hypoglycemic preparations
  • Diabetic microangiopathy in KK mice. VI. Effect of glycemic control on renal glycoprotein metabolism and established glomerulosclerosis.
  • Insulin release and peripheral sensitivity at the oral glucose tolerance test.
  • P2-purinoceptor-mediated membrane currents in DDT1 MF-2 smooth muscle cells.
  • Effects of glipizide on beta-endorphin concentration in the brain of genetically diabetic (db/db) mice.
  • Effect of glipizide on the surgically altered pancreas.
  • Prorenin and vascular complications of diabetes.
  • Phototoxicity to diuretics and antidiabetics in the cultured keratinocyte cell line HaCaT: evaluation by clonogenic assay and single cell gel electrophoresis Comet assay).
  • Effect of sulfonylureas on hepatic glycogen metabolism: activation of glycogen phosphorylase.
  • The effect of hypoglycemic sulfonylureas on human red blood cell transglutaminase activity.
  • Effect of glipizide on hepatic fructose 2,6-bisphosphate concentration and glucose metabolism.
  • Sulphonamide modulation of sodium content in rat pancreatic islets.
  • Glyburide and glipizide in treatment of diabetic patients with secondary failures to tolazamide or chlorpropamide.
  • Clinical efficacy of a Minidiab preparation (glipizide) in an acute experiment
  • Trends in use of oral hypoglycemic agents 1964-1986.
  • Effect of glipizide on insulin secretion and insulin metabolism in obese type II diabetic patients.
  • High-performance liquid chromatographic determination of glipizide in human plasma and urine.
  • Effects of glipizide on various consecutive insulin secretory stimulations in patients with type 2 diabetes.
  • Transdermal delivery of glibenclamide and glipizide: in vitro permeation studies through mouse skin.
  • Monitoring and controlling the patient with non-insulin-dependent diabetes mellitus.
  • The effect of glipizide on HDL and HDL subclasses.
  • Pancreatic beta-cell K(ATP) channel activity and membrane-binding studies with nateglinide: A comparison with sulfonylureas and repaglinide.
  • Glibenclamide is exceptional among hypoglycaemic sulphonylureas in accumulating progressively in beta-cell-rich pancreatic islets.
  • Stimulation of pancreatic polypeptide secretion in the dog by hypoglycemic agent HB 699.
  • Mechanism of action of the second-generation sulfonylurea glipizide.
  • Effect of glipizide treatment on various aspects of glucose, insulin, and lipid metabolism in patients with noninsulin-dependent diabetes mellitus.
  • Insulin binding on MOLT 4 cells: effect of a sulfonylurea.
  • Indobufen interacts with the sulphonylurea, glipizide, but not with the beta-adrenergic receptor antagonists, propranolol and atenolol.
  • Adsorption of sulfonylureas onto activated charcoal in vitro.
  • Differential effects of K(ATP) channel blockers on (3)H-noradrenaline overflow after short- and long-term exposure to (+)-oxaprotiline or desipramine.
  • Effect of sulfonylurea treatment on in vivo insulin secretion and action in patients with non-insulin-dependent diabetes mellitus.
  • Diurnal pattern of plasma insulin and blood glucose during glibenclamide and glipizide therapy in elderly diabetics.
  • Glycosylated hemoglobin and fasting plasma glucose in the assessment of outpatient glycemic control in NIDDM.
  • Sulfonylurea treatment of insulin-independent diabetes mellitus.
  • Effect of glipizide on muscle metabolism in vitro.
  • Influence of food intake on the absorption and effect of glipizide in diabetics and in healthy subjects.
  • Impaired effect of sulfonylurea following increased dosage.
  • Lipid metabolism in non-insulin-dependent diabetes mellitus: effect of glipizide therapy.
  • Radioimmunoassay of glipizide in human plasma.
  • Effects of gliclazide--a new antidiabetic agent--on blood platelet function in vitro and in vivo.
  • Treatment of feline diabetes mellitus using an alpha-glucosidase inhibitor and a low-carbohydrate diet.
  • Pharmacokinetics and bioavailability of glipizide capsules
  • Supramaximal decrease of sulphonylurea-induced accumulation of sodium in pancreatic islets.
  • Characterization of pancreatic beta cell receptors binding sulfanilamide drugs
  • Glipizide stimulates sympathetic outflow in diabetes-prone mice.
  • Sulfonylureas mimic glucose in stimulating the uptake of Na+ in pancreatic islets exposed to ouabain.
  • Modulation of beta-cell activity and its influence on islet cell antibody (ICA) and islet cell surface antibody (ICSA) reactivity.
  • Effects of glipizide on glucose metabolism and muscle content of the insulin-regulatable glucose transporter (GLUT 4) and glycogen synthase activity during hyperglycaemia in type 2 diabetic patients.
  • Comparative placental transport of oral hypoglycemic agents in humans: a model of human placental drug transfer.
  • Effects of antidiabetic sulphonylureas, cromakalim and their interaction in guinea-pig isolated tracheal smooth muscle.
  • Comparison of the pharmacokinetics of glipizide and glibenclamide in man.
  • Modification of cardiovascular response of posterior hypothalamic adenosine A(2) receptor stimulation by adenylate cylase, guanylate cyclase and by K(ATP) channel blockade in anesthetized rats.
  • Non-saturable cooperative binding of tolbutamide to rat endocrine pancreas. Criteria of specificity
  • Cosecretion of islet amyloid polypeptide (IAPP) and insulin from isolated rat pancreatic islets following stimulation or inhibition of beta-cell function.
  • Evidence that imidazol(id)ine- and sulphonylurea-based antagonists of cromakalim act at different sites in the rat thoracic aorta.
  • Alcohol tolerance in patients with non-insulin-dependent diabetes (type 2) treated orally with drugs--derivatives of sulphonylurea
  • Iterative stimulation of pancreatic islets by glipizide.
  • Alteration of rat hepatic insulin metabolism by glyburide and glipizide.
  • Concentration and separation of hypoglycemic drugs using solid-phase extraction-capillary electrophoresis.
  • Stress-induced hyperglycemia and hypoinsulinemia are suppressed by sulfonylurea. Predominant role of insulin.
  • Five year retrospective evaluation of sulfonylurea ingestion in children.
  • Effects of K+ channel blockers and openers on antinociception induced by agonists of 5-HT1A receptors.
  • Economic model of first-line drug strategies to achieve recommended glycaemic control in newly diagnosed type 2 diabetes mellitus.
  • A novel mechanism of glipizide sulfonylurea action: decreased metabolic clearance rate of insulin.
  • Phototoxicity due to sulphonamide derived oral antidiabetics and diuretics: investigations in a cell culture model.
  • Photodegradation products of sulphonamide-derived oral antidiabetics and diuretics are not phototoxic in vitro.
  • How safe are bioequivalence studies in healthy volunteers?
  • The effect of oral hypoglycaemic agents on dyslipidaemia in Nigerian patients with newly diagnosed non-insulin dependent diabetes mellitus--a prospective study.
  • Pharmacological characterization of the sulphonylurea receptor in rat isolated aorta.
  • Sulphonylurea binding in rat isolated glomeruli: pharmacological characterization and dependence on cell metabolism and cytoskeleton.
  • Inhibiting effects of antioxidants on drug-induced phototoxicity in cell cultures. Investigations with sulphonamide-derived oral antidiabetics and diuretics.
  • Glycosylated hemoglobin concentration for assessment of glycemic control in diabetic cats.
  • Bradykinin, lemakalim and sodium nitroprusside relax the mouse trachea in vitro by different mechanisms.
  • Presentation and 5-year follow-up of type 2 diabetes mellitus in African-American and Caribbean-Hispanic adolescents.
  • Evaluation of phototoxic properties of oral antidiabetics and diuretics. Photohemolysis model as a screening method for recognizing potential photosensitizing drugs.
  • Capillary electrophoretic detection of metabolites in the urine of patients receiving hypoglycemic drug therapy.
  • Effect of potassium channel openers on the firing rate of hippocampal pyramidal cells and A10 dopaminergic neurons in vitro.
  • Effects of K+ channel blockers on the anoxic response of CNS myelinated axons.
  • Flufenamic and tolfenamic acids and lemakalim relax guinea-pig isolated trachea by different mechanisms.
  • Glipizide treatment of post-transplant diabetes does not interfere with cyclosporine pharmacokinetics in renal allograft recipients.
  • Decreased responsiveness of gluconeogenesis to the modulation by sulfonylureas in hepatocytes isolated from obese (fa/fa) Zucker rats.
  • Changes in (3)Hglibenclamide binding to mouse forebrain membranes during morphine tolerance.
  • Preliminary evaluation of glipizide spheres and compacts from spheres prepared by cross-linking technique.
  • Evaluation of bioadhesive glipizide spheres and compacts from spheres prepared by extruder/marumerizer technique.
  • Dynamics of sulfonylurea-induced insulin release from the isolated perfused rat pancreas.







    online pharmacies || Hair Million herbal formula for hair loss and hair growth || Amoxicillin || Tramadol || Paxil || Rx Drugs USA, Prescription Drugs Online Pharmacy || Zithromax || online pharmacy || Antibiotics and prescription medications online literature || Antibiotics